Login to Your Account

Genfit, Sanofi-Aventis Ink $54M Deal for Metabolic Disorders

By Marie Powers

Wednesday, March 23, 2011
Extending a partnership that dates back to 1999, Genfit, of Lille, France, has inked an agreement with Sanofi-Aventis SA, of Paris, to pursue therapies for the treatment of metabolic disorders. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription